Back
MannKind 10K Form
Buy
67
MNKD
MannKind
Last Price:
$5.17
Seasonality Move:
14.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | MNKD/MannKind Quarterly |
| 2023-11-07 | 10Q | MNKD/MannKind Quarterly |
| 2023-08-07 | 10Q | MNKD/MannKind Quarterly |
| 2023-05-09 | 10Q | MNKD/MannKind Quarterly |
| 2022-11-08 | 10Q | MNKD/MannKind Quarterly |
| 2022-08-09 | 10Q | MNKD/MannKind Quarterly |
Receive MNKD News And Ratings
See the #1 stock for the next 7 days that we like better than MNKD
MNKD Financial Statistics
Sales & Book Value
| Annual Sales: | $285.5M |
|---|---|
| Cash Flow: | $19.7M |
| Price / Cash Flow: | 46.85 |
| Annual Sales: | $-0.26 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 0.10000 |
|---|---|
| Net Income (TTM): | $27.6M |
| Gross Margin: | $208.9M |
| Return on Equity: | 0% |
| Return on Assets: | 6.11% |
MannKind Earnings Forecast
Key MannKind Financial Ratios
-
The Gross Profit Margin over the past 20 years for MNKD is 73.17%.
-
The Selling, General & Administrative Expenses for MNKD have been equal to 33.04% of Gross Profit Margin.
-
The Research & Development expenses have been 16.07% of Revenue.
-
The Interest Expense is 137.67% of Operating Income.
-
The Net Earning history of MNKD is 9.66% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 16 years.
MannKind Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MNKD |
| CUSIP: | 56400P |
| Website: | mannkindcorp.com |
Debt
| Debt-to-Equity Ratio: | -0.46 |
|---|---|
| Current Ratio: | 3.28 |
| Quick Ratio: | 2.55 |
Price-to-Earnings
| Trailing P/E Ratio: | 52.4 |
|---|---|
| Forward P/E Ratio: | 0 |